Surgery Partners operates outpatient surgical facilities and related care services across the United States. SGRY reports earnings on Mon, Nov 9, 2026. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell). In the past 30 days there were 6 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 28 | UBS | Downgrade | Hold | |
| Sep 30 | RBC Capital | Reiterated | Buy | |
| Sep 25 | Benchmark | Reiterated | Buy | |
| Sep 14 | JP Morgan | Maintained | Hold | |
| Aug 11 | TD Cowen | Maintained | Buy |
Whale Options Flow
90DNo whale options trades in SGRY in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGRY is in one of them and how their past SGRY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SGRY in an article yet. Here's the latest on the wider market.
About Surgery Partners
Surgery Partners operates a national network of surgical facilities across the United States. Its facilities include outpatient surgery centers, surgical hospitals, anesthesia services, urgent care clinics and physician practices, with most focused on planned procedures that do not require a hospital stay. Its patients are mainly covered by private insurance and government programs such as Medicare. The company is based in Brentwood, Tennessee.
- Headquarters
- Brentwood, TN